Brain and other central nervous system tumors: Rates, trends, and epidemiology

Current Opinion in Oncology

Volumn 13, Issue 3, 2001, Pages 160-166

  Gurney, James G ^a,b   Kadan Lottick, Nina ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN LYMPHOMA; BRAIN TUMOR; CANCER REGISTRY; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; ELECTROMAGNETIC FIELD; FEMALE; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; REVIEW; RISK FACTOR; STANDARDIZATION;

AGE DISTRIBUTION; BRAIN NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; REGISTRIES; SEX DISTRIBUTION; SURVIVAL RATE; UNITED STATES;

EID: 0035041023     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200105000-00005     Document Type: Review

References (75)

1. 1 Heideman RL, Packer RJ, Albright LA, et al.: Tumors of the central nervous system. In Principles and Practices of Pediatric Oncology, edn 3. Edited by Pizzo PA, Poplack DG. Philadelphia: Lippincott-Raven; 1997:633-697.
2. 2 Kleihues P, Cavenee WK: Pathology and Genetics: Tumours of the Nervous System. Lyon: International Agency for Research on Cancer; 1997.
3. 3 SEER Cancer Incidence Public Use Database 1973-1997. Bethesda, MD: Surveillance, Epidemiology, and End Results Program, National Cancer Institute; 2000. Surveillance, Epidemiology, and End Results public use data available on CD with statistical software at: http://www-seer.ims.nci.nih.gov/Publications/.
4. 4 Greenlee RT, Murray T, Bolden S, et al.: Cancer statistics, 2000. CA Cancer J Clin 2000, 50:7-33. Provides estimates for the year 2000 on cancer numbers, rates, and trends by site, with some information from individual states in the United States. Also provides cancer death rates for selected countries around the world.
5. 5 Ries LAG, Eisner MP, Kosary CL, et al.: SEER Cancer Statistics Review 1973-1997. Bethesda, MD: National Cancer Institute; 2000. Detailed tabular presentation of cancer data from the SEER program. Available in hard copy or on line at: http://www-seer.ims.nci.nih.gov/Publications/.
6. 6 Percy C, Van Holten V, Muir C: International Classification of Diseases for Oncology, edn 2. Geneva: World Health Organization; 1990.
7. 7 Central Brain Tumor Registry of the United States: Statistical Report: Primary Brain Tumors in the United States, 1992-1997. Chicago: Central Brain Tumor Registry of the United States; 2000.
8. 8 Gurney JG, Wall DA, Jukich PJ, et al.: The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States. Cancer Causes Control 1999, 10:101-105. Provides histology-specific incidence rates for childhood brain tumors, including nonmalignancies.
9. 9 Szklo M, Nieto FJ: Epidemiology: Beyond the Basics. Gaithersburg, MD: Aspen Publishers; 2000.
10. 10 Taylor TH, Anton-Culver H: Let's leave the date out of the name of the standard population. J Natl Cancer Inst 2000, 92:1269-1270. Discusses potential problems with changing the reference population for standardized cancer rates.
11. 11 Ahlbom A, Rodvall Y: Brain tumour trends. Lancet 1989, 2:1272-1273.
12. 12 Levi F, La Vecchia C: Trends in brain cancer. Lancet 1989, 2:917.
13. 13 Greig NH, Ries LG, Yancik R, et al.: Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1990, 82:1621-1624.
14. 14 Mao Y, Desmeules M, Semenciw RM, et al.: Increasing brain cancer rates in Canada, Can Med Assoc J 1991, 145:1583-1591.
15. 15 Polednak AP: Time trends in incidence of brain and central nervous system cancers in Connecticut. J Natl Cancer Inst 1991, 83:1679-1681.
16. 16 Modan B, Wagener DK, Feldman JJ, et al.: Increased mortalìty from braín tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol 1992, 135:1349-1357.
17. 17 Desmeules M, Mikkelsen T, Mao Y: Increasing incidence of primary malignant brain tumors: influence of diagnostic methods. J Natl Cancer Inst 1992, 84:442-445.
18. 18 Larsen NS: Brain tumor incidence rising; researchers ask why. J Natl Cancer Inst 1993, 85:1024-1025.
19. 19 Munasinghe RL, Morris RD: RE: increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol 1993, 138:551-552.
20. 20 Polednak AP: Re: increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol 1994, 140:1138-1143.
21. 21 Ahsan H, Neugut Al, Bruce JN: Trends in incidence of primary malignant brain tumors in USA, 1981-1990. Int J Epidemiol 1995, 24:1078-1085.
22. 22 Devesa SS, Blot WJ, Stone BJ, et al.: Recent cancer trends in the United States. J Natl Cancer Inst 1995, 87:175-182.
23. 23 Olney JW, Farber NB, Spitznagel E, et al.: Increasing brain tumor rates: is there a link to aspartame? J Neuropathol Exp Neurol 1996, 55:1115-1123.
24. 24 Black WC: Increasing incidence of childhood primary malignant brain tumors: enigma or no-brainer? J Natl Cancer Inst 1998, 90:1249-1251.
25. 25 Smith MA, Feidlin B, Ries LAG, et al.: Response. J Natl Cancer Inst 1998, 90:1269-1277.
26. 26 Smith MA, Freidlin B, Ries LA, et al.: Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 1998, 90:1269-1277.
27. 27 Forman AD: Re: trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 1999, 91:648-649.
28. 23 Varner AE: Re: trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 1999, 91:973.
29. 29 Gurney JG: Topical topics: brain cancer incidence in children: time to look beyond the trends. Med Pediatr Oncol 1999, 33:110-112.
30. 30 Legler JM, Ries LAG, Smith MA, et al.: Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999, 91:1382-1390. Excellent evaluation of reasons for adult brain cancer trends.
31. 31 Linet MS, Ries LAG, Smith MA, et al.: Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 1999, 91:1051-1058.
32. 32 Mangano JJ: A rise in the incidence of childhood cancer in the United States. Int J Health Serv 1999, 29:393-408.
33. 33 Schechter CB: Re: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999, 91:2050-2051.
34. 34 Bukowski JA: Critical assessment of opposing views on trends in childhood cancer. Int J Health Serv 2000, 30:373-377.
35. 35 Gurney JG, Davis S, Severson RK, et al.: Trends in cancer incidence among children in the US. Cancer 1996, 78:532-541.
36. 36 Bunin GR, Feuer EJ, Witman PA, et al.: Increasing incidence of childhood cancer: report of 20 years experience from the Greater Delaware Valley Pediatric Tumor Registry, Paediatr Perinat Epidemiol 1996, 10:319-338.
37. 37 Davis DL, Ahlbom A, Hoel D, et al.: Is brain cancer mortality increasing in industrial countries? Am J Ind Med 1991, 19:421-431.
38. 38 Gurney JG, Smith MA, Bunin GR: CNS and miscellaneous intracranial and intraspinal neoplasms. In Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995, Edited by Ries LAG, Smith MA, Gurney JG, et al. Bethesda, MD: National Cancer Institute Cancer Surveillance Research Program; 1999:51-63. The monograph provides a comprehensive presentation of epidemiologic data on childhood cancer incidence and survival by histology. Available in hard copy or online from SEER at: http://www-seer.ims.nci.nih.gov/Publications/PedMono/.
39. 39 Hao D, DiFrancesco LM, Brasher PM, et al.: Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996. Ann Oncol 1999, 10:65-70.
40. 40 Phan TG, O'Neill BP, Kurtin PJ: Posttransplant primary CNS lymphoma. Neuro-oncology 2000, 2:229-238.
41. 41 Schabet M: Epidemiology of primary CNS lymphoma, J Neurooncol 1999, 43:199-201.
42. 42 Tirelli U, Spina M, Gaidano G, et al.: Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy. AIDS 2000, 14:1675-1688.
43. 43 Levine AM: Acquired immunodeficiency syndrome-related lymphoma: clinical aspects. Semin Oncol 2000, 27:442-453.
44. 44 Franceschi S, Dal Maso L, La Vecchia C: Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Int J Cancer 1999, 83:481-485.
45. 45 Cingolani A, Gastaldi R, Fassone L, et al.: Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas. J Clin Oncol 2000, 18:3325-3330.
46. 46 Cohen JI: Epstein-Barr virus infection. N Engl J Med 2000, 343:481-492.
47. 47 Biggar RJ, Frisch M, Goedert JJ: Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA 2000, 284:205-209. Important paper evaluating cancer rates in children with AIDS.
48. 48 Little J: Epidemiology of Childhood Cancer. Lyon: International Agency for Research on Cancer; 1999. Provides the most detailed critical review available of epidemiologic studies of childhood cancer risk factors.
49. 49 Davis FG, Preston-Martin S; Epidemiology: incidence and survival. In Russell & Rubinstein's Pathology of Tumors of the Nervous System, edn 6. Edited by Bigner DD, McLendon RE, Bruner JM. New York: Oxford University Press; 1998:5-45.
50. 50 Bondy ML, Wrensch MR: Epidemiology of primary malignant brain tumors. Baillieres Clin Neurol 1996, 5:251-270.
51. 51 Inskip PD, Linet MS, Heineman EF: Etiology of brain tumors in adults. Epidemiol Rev 1995, 17:382-414.
52. 52 Kuijten RR, Bunin GR: Risk factors for childhood brain tumors. Cancer Epidemiol Biomarkers Prev 1993, 2:277-288.
53. 53 Gurney JG, Smith MA, Olshan AF, et al.: Clues to the etiology of childhood brain cancer: N-nitroso compounds, polyomaviruses and other factors of interest. Cancer Invest 2001, 19:in press.
54. 54 Shah KV: Polyoma viruses (JC virus, BK virus, and simian virus 40) and human cancer. In Infectious Causes of Cancer: Targets for Intervention. Edited by Goedert JJ. Totowa, NJ: Humana Press; 2000:461-474.
55. 55 Shah KV: Does SV40 infection contribute to the development of human cancers? Rev Med Virol 2000, 10:31-43. Describes why caution is necessary when interpreting the potential role of simian virus 40 in human brain tumor etiology.
56. 56 Sampson JH, Bigner DD: Experimental tumors and the evaluation of neurocarcinogens. In Russell & Rubinstein's Pathology of Tumors of the Nervous System, edn 6. Edited by Bigner DD, McLendon RE, Bruner JM. New York: Oxford University Press; 1998:167-230.
57. 57 Wrensch M, Yost M, Miike R, et al.: Adult glioma in relation to residential power frequency electromagnetic field exposures in the San Francisco Bay area. Epidemiology 1999, 10:523-527.
58. 58 Gurney JG, van Wijngaarden E: Extremely low frequency electromagnetic fields (EMF) and brain cancer in adults and children: review and comment. Neuro-oncology 1999, 1:1-9.
59. 59 Portier CJ, Wolfe MS: Assessment of health effects from exposure to power-line frequency electric and magnetic fields: NIEHS Working Group report. Research Triangle Park, NC: National Institute of Environmental Health Sciences; 1998. NIH publication no. 98-3981.
60. 60 Morehouse CA, Owen RD: Exposure of Daudi cells to low-frequency magnetic fields does not elevate MYC steady-state mRNA levels. Radiat Res 2000, 153:663-669.
61. 61 Morehouse CA, Owen RD: Exposure to low-frequency electromagnetic fields does not alter HSP70 expression or HSF-HSE binding in HL60 cells. Radiat Res 2000, 153:658-662.
62. 62 Boorman GA, Owen RD, Lotz WG, et al.: Evaluation of in vitro effects of 50 and 60 Hz magnetic fields in regional EMF exposure facilities. Radiat Res 2000, 153:648-657.
63. 63 Desta AB, Owen RD, Cress LW: Ornithine decarboxylase activity in developing chick embryos after exposure to 60-hertz magnetic fields, Biochem Biophys Res Commun 1999, 265:211-213.
64. 64 Cress LW, Owen RD, Desta AB: Ornithine decarboxylase activity in L929 cells following exposure to 60 Hz magnetic fields. Carcinogenesis 1999, 20:1025-1030.
65. 65 Owen RD: Possible health risks of radiofrequency exposure from mobile telephones. Epidemiology 2000, 11:99-100.
66. 66 Elwood JM: A critical review of epidemiologic studies of radiofrequency exposure and human cancers. Environ Health Perspect 1999, 107(suppl 1): 155-168.
67. 67 Repacholi MH: Low-level exposure to radiofrequency electromagnetic fields: health effects and research needs. Bioelectromagnetics 1998, 19:1-19.
68. 68 Rothman KJ, Loughlin JE, Funch DP, et al.: Overall mortality of cellular telephone customers, Epidemiology 1996, 7:303-305.
69. 69 Rothman KJ, Chou CK, Morgan R, et al.: Assessment of cellular telephone and other radio frequency exposure for epidemiologic research. Epidemiology 1996, 7:291-298.
70. 70 Morgan RW, Kelsh MA, Zhao K, et al.: Radiofrequency exposure and mortality from cancer of the brain and lymphatic/hematopoietic systems. Epidemiology 2000, 11:118-127.
71. 71 Inskip PD, Tarone RE, Hatch EE, et al.: Cellular telephone use and brain tumors. N Engl J Med 2001, 344:79-86.
72. 72 Institute Statistical Research Applications Branch: Available at http://www-dccps.ims.nci.nih.gov/SRAB/Prevalence/National Cancer. Accessed November 2000. Cancer prevalence data available in tabular form from the National Cancer Institute.
73. 73 Siffert J, Greenleaf M, Mannis R, et al.: Pediatric brain tumors. Child Adolesc Psychiatr Clin North Am 1999, 8:879-903.
74. 74 Sklar C, Whitton J, Mertens A, et al.: Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Children's Cancer Survivors Study. J Clin Endocrinol Metab 2000, 85:3227-3232.
75. 75 Perera FP: Molecular epidemiology: on the path to prevention? J Natl Cancer Inst 2000, 92:602-612.